View in EDS

3191eP Development of an EORTC strategy to measure health-related quality of life in cancer patients receiving immune checkpoint inhibitors: Phase I and II.

Saved in:
Bibliographic Details
Title: 3191eP Development of an EORTC strategy to measure health-related quality of life in cancer patients receiving immune checkpoint inhibitors: Phase I and II.
Authors: Fox, L.1 (AUTHOR), Egeler, M.2 (AUTHOR), Singer, S.3 (AUTHOR), Brédart, A.4 (AUTHOR), Kiyota, N.5 (AUTHOR), Saad, A.6 (AUTHOR), Abaza, H.7 (AUTHOR), De Padova, S.8 (AUTHOR), Lee, R.J.9 (AUTHOR), Wu, Y.10 (AUTHOR), Lai-Kwon, J.E.11 (AUTHOR), Enting, D.12 (AUTHOR), Bonilla, S.A.Z.13 (AUTHOR), Abdel-Razeq, H.7 (AUTHOR), Matsumoto, S.5 (AUTHOR), van Leeuwen, M.2 (AUTHOR), Van Hemelrijck, M.1 (AUTHOR)
Source: Annals of Oncology. 2025 Supplement 2, Vol. 36, pS695-S695. 1p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 189419471
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: 3191eP Development of an EORTC strategy to measure health-related quality of life in cancer patients receiving immune checkpoint inhibitors: Phase I and II.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Fox%2C+L%2E%22">Fox, L.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Egeler%2C+M%2E%22">Egeler, M.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Singer%2C+S%2E%22">Singer, S.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Brédart%2C+A%2E%22">Brédart, A.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kiyota%2C+N%2E%22">Kiyota, N.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Saad%2C+A%2E%22">Saad, A.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Abaza%2C+H%2E%22">Abaza, H.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22De+Padova%2C+S%2E%22">De Padova, S.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lee%2C+R%2EJ%2E%22">Lee, R.J.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wu%2C+Y%2E%22">Wu, Y.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lai-Kwon%2C+J%2EE%2E%22">Lai-Kwon, J.E.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Enting%2C+D%2E%22">Enting, D.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bonilla%2C+S%2EA%2EZ%2E%22">Bonilla, S.A.Z.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Abdel-Razeq%2C+H%2E%22">Abdel-Razeq, H.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Matsumoto%2C+S%2E%22">Matsumoto, S.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22van+Leeuwen%2C+M%2E%22">van Leeuwen, M.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Van+Hemelrijck%2C+M%2E%22">Van Hemelrijck, M.</searchLink><relatesTo>1</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2025 Supplement 2, Vol. 36, pS695-S695. 1p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=189419471
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.annonc.2025.08.1662
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 1
        StartPage: S695
    Titles:
      – TitleFull: 3191eP Development of an EORTC strategy to measure health-related quality of life in cancer patients receiving immune checkpoint inhibitors: Phase I and II.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Fox, L.
      – PersonEntity:
          Name:
            NameFull: Egeler, M.
      – PersonEntity:
          Name:
            NameFull: Singer, S.
      – PersonEntity:
          Name:
            NameFull: Brédart, A.
      – PersonEntity:
          Name:
            NameFull: Kiyota, N.
      – PersonEntity:
          Name:
            NameFull: Saad, A.
      – PersonEntity:
          Name:
            NameFull: Abaza, H.
      – PersonEntity:
          Name:
            NameFull: De Padova, S.
      – PersonEntity:
          Name:
            NameFull: Lee, R.J.
      – PersonEntity:
          Name:
            NameFull: Wu, Y.
      – PersonEntity:
          Name:
            NameFull: Lai-Kwon, J.E.
      – PersonEntity:
          Name:
            NameFull: Enting, D.
      – PersonEntity:
          Name:
            NameFull: Bonilla, S.A.Z.
      – PersonEntity:
          Name:
            NameFull: Abdel-Razeq, H.
      – PersonEntity:
          Name:
            NameFull: Matsumoto, S.
      – PersonEntity:
          Name:
            NameFull: van Leeuwen, M.
      – PersonEntity:
          Name:
            NameFull: Van Hemelrijck, M.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 09
              Text: 2025 Supplement 2
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 09237534
          Numbering:
            – Type: volume
              Value: 36
          Titles:
            – TitleFull: Annals of Oncology
              Type: main
ResultId 1